Results 51 to 60 of about 16,478 (220)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Regional drought in the southern of South America: physical aspects Seca regional no sul da América do Sul: aspectos físicos

open access: yesRevista Brasileira de Meteorologia, 2010
From the indices of monthly and annual climatic drought in six regions in southern South America and their associations with seventeen predictors, the probable physical causes of droughts are analyzed.
Juan Leonidas Minetti   +3 more
doaj   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Caminhando pelas Ruas de Desterro – Santa Catarina - Brasil

open access: yesCaminho Aberto: Revista de Extensão do IFSC, 2018
Para atender a demanda da atividade turística e propiciar qualidade no atendimento nos serviços, o projeto Caminhando pelas Ruas de Desterro - SC teve como objetivo oferecer a atividade de educação patrimonial junto a trabalhadores da cidade através de ...
Maria Helena Alemany Soares   +2 more
doaj   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Apresentação

open access: yesHoplos, 2019
Em 1º de janeiro de 2003, durante a sessão de posse no Congresso Nacional, o então presidente Luiz Inácio Lula da Silva anunciou que as relações internacionais de seu governo seriam orientadas para “a construção de uma América do Sul politicamente ...
Leandro Gavião
doaj   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Política regional e projeção de interesses privados:

open access: yesCarta Internacional, 2019
O artigo tem como objetivo discutir o papel da América do Sul na política externa dos governos de Luiz Inácio Lula da Silva (2003-2010). Desenvolve-se ao longo do texto o argumento de que a América do Sul foi o espaço prioritário de articulação da ...
Karen dos Santos Honorio
doaj   +1 more source

Home - About - Disclaimer - Privacy